Growth Metrics

ProQR Therapeutics (PRQR) Net Cash Flow (2021 - 2025)

Historic Net Cash Flow for ProQR Therapeutics (PRQR) over the last 2 years, with Q4 2022 value amounting to -$4.1 million.

  • ProQR Therapeutics' Net Cash Flow fell 11181.81% to -$4.1 million in Q4 2022 from the same period last year, while for Sep 2025 it was $0.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $29.4 million for FY2024, which is 1527.14% up from last year.
  • According to the latest figures from Q4 2022, ProQR Therapeutics' Net Cash Flow is -$4.1 million, which was down 11181.81% from -$59.9 million recorded in Q3 2022.
  • In the past 5 years, ProQR Therapeutics' Net Cash Flow registered a high of $88.3 million during Q2 2021, and its lowest value of -$59.9 million during Q3 2022.